Five-year median 31.0×, middle half 27.1–37.8×, range 20.6–43.3×. Now 44.8×: +44% above its own median, higher than 100% of those quarters.Each quarter priced at its own trailing Cash FFO per share · the band is the 25th–75th percentile
Where the cash goes
TTM through Jun 30, 2026 · $B
Cash FFO 3.84B = net income 1.35B + depreciation 2.50B − 0.00B other non-cash items · dividends 2.25B · retained 1.59B
Against its type
WELL (blue) vs. the other Healthcare REITs on the board (3), grey
P/Cash FFO44.8× vs. 17.2×
Dividend yield1.3% vs. 4.9%
Cash FFO payout59% vs. 76%
Net debt / EBITDA5.6× vs. 4.9×
Interest cover4.3× vs. 4.4×
EBITDA margin25% vs. 60%
Type averages are the plain mean of the other REITs of the same property type with a usable window.
Quarter by quarter
8 quarters · Sep 30, 2024 → Jun 30, 2026 · a gap is a dropped quarter